ImportRefusal LogoImportRefusal

Beximco Pharmaceuticals

⚠️ Moderate Risk

FEI: 3005079166 • Tongi Opsonin • BANGLADESH

FEI

FEI Number

3005079166

📍

Location

Tongi Opsonin

🇧🇩

Country

BANGLADESH
🏢

Address

Bangledash Square, , Tongi Opsonin, , Bangladesh

Moderate Risk

FDA Import Risk Assessment

43.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

2
Total Refusals
1
Unique Violations
6/28/2005
Latest Refusal
6/28/2005
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
17.7×30%
Recency
0.0×20%
Frequency
20.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
6/28/2005
62KCP06MALETHAMER (ANTI-PERISTALTIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
6/28/2005
62KCP10OMEPRAZOLE (ANTI-PERISTALTIC, ANTI-DIARRHEAL)
75UNAPPROVED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Beximco Pharmaceuticals's FDA import refusal history?

Beximco Pharmaceuticals (FEI: 3005079166) has 2 FDA import refusal record(s) in our database, spanning from 6/28/2005 to 6/28/2005.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Beximco Pharmaceuticals's FEI number is 3005079166.

What types of violations has Beximco Pharmaceuticals received?

Beximco Pharmaceuticals has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Beximco Pharmaceuticals come from?

All FDA import refusal data for Beximco Pharmaceuticals is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.